Skip to main content
HairCited

Minoxidil per Alopecia areata

A

Basato su 48 studi (2 meta-analyses, 1 RCT) con 21,842 partecipanti totali. 37/48 studi mostrano effetti positivi.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

In sintesi

Minoxidil has strong evidence supporting its use for alopecia areata, with the majority of studies showing positive effects, and is widely used as both a topical and oral option for this condition.

  • 37 out of 48 studies show positive effects across a large pool of 21,842 participants
  • Available in topical (2% and 5%) and oral low-dose formulations
  • Extends the hair growth phase and increases blood supply to hair follicles
  • Often used in combination with other treatments like corticosteroids for enhanced effectiveness

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: women with androgenetic alopecia (female pattern hair loss)

Case Reports n=1
Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case …
Dose: None vs: None Outcome: hair regrowth in severe alopecia areata Effetto: None None

Popolazione: patient with severe alopecia areata with suboptimal response to tofacitinib

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo Effetto: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
Review
Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: None

review
The Use of Light-Based Therapies in the Treatment of Alopecia.
Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri vs: Placebo Effetto: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None
retrospective cohort study n=321
Asynchronous Teledermatology for Non-Scarring Alopecia: A Retrospective Study.
Dose: Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi vs: Placebo Effetto: 91.3% received definitive remote diagnosis; only 8.7% required in-person follow-up. AA most common ( None

Key Statistics

122

Studi

27416

Partecipanti

Positive

A

Grado

Referenced Papers

Dermatologic clinics 2025 5 citazioni
Pediatric dermatology 2025 5 citazioni
Journal of the … 2025 2 citazioni
International journal of … 2025 1 citazioni
Journal of clinical … 2025 1 citazioni
Archives of dermatological … 2025
International journal of … 2024 39 citazioni
American family physician 2024 8 citazioni
Skin health and … 2024 7 citazioni
Journal of the … 2024 7 citazioni
The Journal of … 2024 2 citazioni
Archives of dermatological … 2023 16 citazioni
The Cochrane database … 2023 2 citazioni
The Journal of … 2022 170 citazioni
Journal of the … 2022 90 citazioni
Dermatology and therapy 2022 43 citazioni
Skin appendage disorders 2022 7 citazioni
The American Journal … 2022 2 citazioni
Journal of dermatological … 2021 51 citazioni
American journal of … 2020 127 citazioni
International journal of … 2020 58 citazioni
The journal of … 2020 3 citazioni
The Australasian journal … 2019 152 citazioni
American journal of … 2019 84 citazioni
Journal of the … 2019 50 citazioni
Expert opinion on … 2019 34 citazioni
Klinicka onkologie : … 2019 11 citazioni
Journal of the … 2018 114 citazioni
Dermatology online journal 2018
American family physician 2017 141 citazioni
American journal of … 2017 32 citazioni
Actas dermo-sifiliograficas 2017 17 citazioni
Deutsches Arzteblatt international 2016 99 citazioni
Current problems in … 2015 322 citazioni
The Medical clinics … 2015 66 citazioni
Canadian family physician … 2015 31 citazioni
The journal of … 2015 25 citazioni
Current problems in … 2015 18 citazioni
Der Internist 2015
Lasers in surgery … 2014 243 citazioni
American journal of … 2014 82 citazioni
Expert opinion on … 2014 57 citazioni
Giornale italiano di … 2014 18 citazioni
Giornale italiano di … 2014
International journal of … 2013 61 citazioni
Recent patents on … 2011 6 citazioni
Seminars in cutaneous … 2009 85 citazioni
American family physician 2009
The Cochrane database … 2008 222 citazioni
Current opinion in … 2008 31 citazioni
International journal of … 2007 185 citazioni
Alopecia areata. Case Report
Dermatology nursing 2007
The Australasian journal … 2006
Journal of the … 2005 44 citazioni
Cleveland Clinic journal … 2005
Praxis 2003 28 citazioni
American family physician 2003 2 citazioni
American family physician 2003
American journal of … 2000 28 citazioni
International journal of … 1999 16 citazioni
Dermatologic clinics 1998 121 citazioni
American family physician 1990
Dermatologic clinics 1987
Journal of the … 1984 122 citazioni
Journal of the … 1984
Archives of dermatology 1984

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

topical:
2-5% solution, twice daily

Limite massimo: 5% topical solution

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Neutral --
None -- Positive 1
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
None -- Mixed --
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri -- Positive --
Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi -- Positive 321
None -- Mixed --
None -- Mixed 1

Momento migliore per l'assunzione: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Effetti collaterali segnalati

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Interazioni note

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Livello di assunzione massimo tollerabile: 5% topical solution

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Minoxidil help with Alopecia areata?
Based on 122 studies with 27,416 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Alopecia areata management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Alopecia areata?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Alopecia areata?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 122 peer-reviewed studies with 27,416 total participants. The overall direction of effect is positive.

Related Evidence

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.